GO:1990074 polyuridylation-dependent mRNA catabolic process: RNA Turnover Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1990074 describes the breakdown of an mRNA molecule that is initiated by the enzymatic addition of a polyuridylyl tail to its 3' end.
• Polyuridylation acts as a molecular tag that recruits decay machineries, coupling 3' end modification to mRNA degradation.
• The process is best characterized in eukaryotes, where it controls mRNA quality and turnover, and is conceptually related to polyadenylation-dependent decay in bacteria and organelles.
• mRNA stability is influenced by codon optimality, and polyuridylation-dependent decay contributes to this layer of post-transcriptional control.
• Chemical modifications of mRNA, such as 2'-O-methylation, can alter stability and may intersect with decay pathways.
• Dysregulation of mRNA decay pathways is linked to cancer biology, including stabilization of oncogenic transcripts such as BRCA1-IRIS.
Description
The polyuridylation-dependent mRNA catabolic process (GO:1990074) is a biological process in which a messenger RNA (mRNA) molecule is targeted for destruction by the enzymatic addition of a stretch of uridylyl residues to its 3' end. This polyuridylation event serves as a signal that recruits cellular decay machinery, leading to the breakdown of the mRNA. The term is defined in the Gene Ontology as the chemical reactions and pathways resulting in the breakdown of an mRNA molecule, initiated by the enzymatic addition of a sequence of uridylyl residues at the 3' end of the target mRNA. Understanding this process is important because mRNA stability is a major determinant of gene expression, and regulated decay allows cells to rapidly adjust protein production in response to developmental and environmental cues. Researchers study polyuridylation-dependent mRNA catabolism to understand how cells maintain transcriptome quality and how defects in RNA turnover contribute to disease. The process is part of a broader network of RNA decay pathways that includes deadenylation, decapping, and exonucleolytic digestion, and it is closely related to polyadenylation-dependent decay in bacteria, archaea, and organelles. Because mRNA half-life directly impacts the amplitude and duration of gene expression, factors that modify or recognize polyuridylated transcripts are of significant interest in cancer biology, immunology, and RNA therapeutics. This article summarizes the current understanding of GO:1990074 based on published literature, covering its definition, mechanism, key genes, regulation, disease relevance, and experimental methods used to study it. It is intended for researchers seeking a concise, citable overview of polyuridylation-dependent mRNA catabolic process and its role in cellular RNA metabolism.
polyuridylation-dependent mRNA catabolic process At A Glance
| GO ID | GO:1990074 |
|---|---|
| GO term | polyuridylation-dependent mRNA catabolic process |
| Ontology | biological_process |
| Synonym | none |
| Major function | Initiation of mRNA breakdown via 3' polyuridylation, tagging transcripts for decay |
| Definition | The chemical reactions and pathways resulting in the breakdown of a messenger RNA (mRNA) molecule, initiated by the enzymatic addition of a sequence of uridylyl residues (polyuridylation) at the 3' end of the target mRNA |
| Related process | Polyadenylation-dependent mRNA decay in bacteria, archaea, and organelles |
| Biological context | Post-transcriptional gene regulation and mRNA quality control |
What Is GO:1990074?
Polyuridylation-dependent mRNA catabolic process (GO:1990074) is the set of chemical reactions and pathways that lead to the breakdown of an mRNA molecule after a sequence of uridylyl residues is added to its 3' end. In this process, the addition of the poly(U) tail acts as the initiating event that marks the mRNA for destruction, distinguishing it from decay pathways that begin with deadenylation or endonucleolytic cleavage. The term encompasses both the enzymatic polyuridylation step and the subsequent steps that result in mRNA degradation.
Why Is polyuridylation-dependent mRNA catabolic process Important in Cell Biology?
Polyuridylation-dependent mRNA catabolic process is important because it provides a regulated entry point into mRNA degradation, allowing cells to control the lifetime of specific transcripts and thereby shape gene expression programs. mRNA decay is tightly coupled to translation and to codon optimality, so pathways that initiate decay through 3' end modification contribute to the fidelity and adaptability of the proteome. In disease contexts, altered mRNA stability can drive oncogenesis; for example, stabilization of the BRCA1-IRIS mRNA in breast cancer cells illustrates how decay pathways influence tumor biology. Understanding GO:1990074 therefore has implications for basic RNA biology, cancer research, and the design of RNA-based therapeutics.
• Controls mRNA half-life and thus the duration and amplitude of gene expression.
• Provides a quality-control mechanism to eliminate aberrant or unwanted transcripts.
• Links 3' end modification to recruitment of decay enzymes, coupling recognition to destruction.
• Contributes to post-transcriptional regulation in development and stress responses.
• Is conceptually related to polyadenylation-dependent decay in bacteria and organelles, informing comparative RNA biology.
• Dysregulation of mRNA decay can contribute to cancer, as seen with stabilized oncogenic transcripts.
• mRNA chemical modifications such as 2'-O-methylation can influence stability and may intersect with decay pathways.
• Understanding decay mechanisms aids in optimizing mRNA therapeutics and vaccines.
• Polyuridylation-dependent decay is part of the broader network of RNA granules and cytoplasmic RNA processing.
• Decay pathways are potential targets for modulating immune responses through RNA stability.
What Happens During polyuridylation-dependent mRNA catabolic process?
Recognition of the target mRNA
In simple terms: The cell first identifies which mRNA molecule should be destroyed.
The polyuridylation-dependent mRNA catabolic process begins when a target mRNA is recognized as a substrate for polyuridylation. This recognition can be influenced by features such as codon optimality, which affects translation elongation and mRNA stability. The process is part of the broader landscape of RNA granules and cytoplasmic RNA processing, where transcripts are sorted for translation, storage, or decay.
Enzymatic addition of the poly(U) tail
In simple terms: An enzyme adds a string of uridine nucleotides to the end of the mRNA.
The defining step of GO:1990074 is the enzymatic addition of a sequence of uridylyl residues to the 3' end of the target mRNA. This polyuridylation event is the initiating modification that distinguishes this pathway from other decay routes. The addition of the poly(U) tail is thought to create a molecular mark that is recognized by downstream decay factors.
Recruitment of decay machinery
In simple terms: Proteins that chew up RNA are recruited to the poly(U) tail.
Following polyuridylation, the poly(U) tail recruits decay machineries that carry out the breakdown of the mRNA. This coupling of modification to degradation ensures that only tagged transcripts are destroyed. The process is integrated with translation, as mRNA decay factors can be associated with ribosomes and RNA granules.
Exonucleolytic degradation of the mRNA
In simple terms: The mRNA is digested from its end until it is completely broken down.
The final stage of the polyuridylation-dependent mRNA catabolic process is the exonucleolytic digestion of the mRNA body, resulting in its breakdown. This step completes the catabolic pathway and releases nucleotides for reuse. The efficiency of this step can be influenced by mRNA modifications and structural features.
Integration with global mRNA turnover
In simple terms: This pathway works together with other decay routes to control the entire pool of mRNAs.
Polyuridylation-dependent decay is one of several pathways that collectively determine mRNA half-lives. It intersects with codon optimality-mediated decay and with quality-control systems that monitor translation. The pathway also operates within the context of RNA granules, which concentrate decay factors and substrates.
Key Genes Involved in GO:1990074 polyuridylation-dependent mRNA catabolic process
The following genes and proteins have been implicated in mRNA stability, polyuridylation-related decay, or associated RNA processing pathways based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| BRCA1 | Tumor suppressor involved in DNA repair and mRNA stability regulation | Loss of BRCA1/p220 triggers BRCA1-IRIS overexpression via mRNA stabilization in breast cancer cells |
| BRCA1-IRIS | Oncogenic isoform overexpressed upon BRCA1 loss | Its mRNA stabilization links decay pathways to breast cancer biology |
| Codon optimality-related genes | Influence translation elongation and mRNA decay | Codon usage affects mRNA stability and degradation |
| 2'-O-methylation machinery | Adds 2'-O-methyl marks to internal mRNA sites | Modifications promote mRNA stability and may intersect with decay |
| Exosomal RNA modification enzymes | Modify extracellular exosomal RNAs | Glyco-modifications on exosomal RNAs relate to RNA processing |
| RNA granule components | Concentrate RNA and decay factors | RNA granules are sites of mRNA processing and decay |
| Polyadenylation factors (bacterial/archaeal/organellar) | Add poly(A) tails in non-eukaryotic systems | Comparative insights into polyuridylation-dependent decay |
| Antigen-encoding RNA modification enzymes | Modify RNA to enhance stability and translation | Relevant to mRNA therapeutic design |
| Cell death regulators | Control apoptosis and RNA stability | Cell death pathways intersect with RNA metabolism |
| Dendritic cell RNA sensors | Recognize modified RNA | RNA stability affects T-cell stimulatory capacity |
| mRNA capping enzymes | Add 5' cap to mRNA | Cap status influences mRNA stability and decay |
| Deadenylases | Remove poly(A) tails | Often act upstream or in parallel to polyuridylation-dependent decay |
| Decapping enzymes | Remove 5' cap | Required for some mRNA decay pathways |
| Exoribonucleases | Degrade mRNA from ends | Execute the final steps of mRNA catabolism |
| RNA helicases | Remodel RNA-protein complexes | Facilitate access of decay factors to mRNA |
| Translation initiation factors | Regulate translation and link to decay | Couple translation status to mRNA stability |
| RNA-binding proteins | Recognize sequence elements in mRNA | Determine substrate specificity for decay |
| Exosome complex components | 3' to 5' exonucleolytic degradation | Central to mRNA turnover |
How Is polyuridylation-dependent mRNA catabolic process Regulated?
The polyuridylation-dependent mRNA catabolic process is regulated at multiple levels, including the availability of polyuridylation enzymes, the recognition of target transcripts, and the coupling of decay to translation. Codon optimality influences translation elongation rates and can affect mRNA stability, thereby modulating the likelihood that a transcript enters decay pathways. Chemical modifications of mRNA, such as 2'-O-methylation, can enhance stability and potentially protect transcripts from degradation. In cancer cells, loss of BRCA1/p220 leads to stabilization of the BRCA1-IRIS mRNA, indicating that specific regulatory factors can override default decay. The process also operates within RNA granules, where local concentrations of decay factors and substrates can be dynamically controlled.
polyuridylation-dependent mRNA catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BRCA1 | Breast cancer, mRNA stabilization of BRCA1-IRIS | BRCA1 knockout breast cancer cell lines |
| BRCA1-IRIS | Oncogenic isoform overexpression | Overexpression and knockdown models |
| 2'-O-methylation writers | mRNA stability and modification-related diseases | Knockout and point-mutation cell models |
| Exosomal RNA modifiers | Extracellular RNA biology and cancer | Exosome isolation and modification profiling |
| Cell death regulators | Apoptosis and RNA turnover | Apoptosis induction models with RNA stability assays |
Cancer and mRNA stability
Dysregulated mRNA stability is a hallmark of cancer, and the polyuridylation-dependent decay pathway may influence the levels of oncogenic transcripts. In breast cancer cells, loss of BRCA1/p220 triggers overexpression of BRCA1-IRIS via mRNA stabilization, demonstrating how decay pathways can be subverted to promote tumorigenesis. Understanding how polyuridylation-dependent decay contributes to the stability of such transcripts could reveal new therapeutic vulnerabilities.
RNA modifications and disease
Chemical modifications of mRNA, including 2'-O-methylation, can alter mRNA stability and may intersect with decay pathways. Aberrant modification patterns could therefore affect the efficiency of polyuridylation-dependent decay and contribute to disease states characterized by altered gene expression. Extracellular exosomal RNAs also carry modifications that may influence their stability and function.
Cell death and RNA metabolism
Apoptosis and other cell death programs are tightly linked to RNA metabolism, and changes in mRNA stability can influence cell survival decisions. The polyuridylation-dependent mRNA catabolic process may contribute to the rapid turnover of transcripts encoding survival or death factors, thereby impacting cell fate. Further research is needed to define the specific roles of this pathway in cell death regulation.
From polyuridylation-dependent mRNA catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene regulate polyuridylation-dependent decay? | CRISPR knockout of the candidate gene followed by mRNA stability assays |
| Does a specific point mutation in a decay factor alter substrate specificity? | CRISPR point-mutation knock-in cell lines |
| Does tagging a decay factor affect its localization? | Knock-in of an epitope tag at the endogenous locus |
| Does overexpression of a polyuridylation enzyme enhance mRNA decay? | CRISPR overexpression models |
| Which transcripts are targeted by polyuridylation-dependent decay? | RNA-seq and poly(U) tail sequencing in knockout vs wild-type cells |
| Does codon optimality influence sensitivity to this decay pathway? | Codon-optimized reporter knock-in models |
How to Study the polyuridylation-dependent mRNA catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global transcript levels | Identifying transcripts affected by decay pathway perturbations |
| Poly(U) tail sequencing | Presence and length of poly(U) tails | Detecting polyuridylation events on mRNAs |
| Ribosome profiling | Translation efficiency and codon occupancy | Linking translation to mRNA decay |
| Quantitative PCR | Levels of specific mRNAs | Measuring stability of candidate transcripts |
| Fluorescence microscopy | Localization of RNA and proteins | Visualizing RNA granules and decay sites |
| CRISPR knockout screens | Gene function at scale | Identifying regulators of mRNA stability |
| Mass spectrometry | Protein interactions and modifications | Characterizing decay complexes |
| Exosome profiling | Extracellular RNA content | Studying modified exosomal RNAs |
RNA stability assays
mRNA stability can be measured by treating cells with transcription inhibitors and monitoring transcript levels over time using quantitative PCR or RNA-seq. These assays are essential to determine whether a gene of interest affects polyuridylation-dependent decay. Codon optimality effects on stability can be assessed with reporter constructs.
Poly(U) tail sequencing
Specialized sequencing methods can detect and quantify poly(U) tails on mRNAs, providing direct evidence of polyuridylation. Such approaches help identify which transcripts are subject to this modification and how it changes under different conditions. Combining with RNA-seq gives a global view of decay targets.
Ribosome profiling
Ribosome profiling measures translation at codon resolution and can reveal how translation elongation rates influence mRNA decay. This method helps link codon optimality to polyuridylation-dependent catabolism. It can be combined with RNA stability measurements to dissect the coupling of translation and decay.
Imaging of RNA granules
Fluorescence microscopy can visualize RNA granules where decay factors concentrate. Live-cell imaging of tagged decay factors and mRNAs can reveal the spatial organization of polyuridylation-dependent decay. This approach is useful for understanding how granule dynamics affect mRNA turnover.
How CRISPR Can Be Used to Study GO:1990074 polyuridylation-dependent mRNA catabolic process
Knockout
CRISPR knockout of candidate genes is a powerful approach to test their role in polyuridylation-dependent mRNA catabolic process. By deleting a putative polyuridylation enzyme or decay factor, researchers can assess changes in mRNA stability and poly(U) tail levels. Knockout models also help distinguish essential from redundant factors in the pathway.
Point Mutation
CRISPR point mutation can be used to introduce specific amino acid substitutions in decay factors to dissect catalytic activity or substrate recognition. Such models are valuable for understanding how individual residues contribute to polyuridylation-dependent decay. Point mutations can also mimic disease-associated variants.
Knock-in
Knock-in of epitope tags or fluorescent proteins at endogenous loci allows visualization and purification of decay factors. Tagged knock-in cell lines enable live-cell imaging of RNA granules and decay complexes. This approach preserves endogenous regulation of gene expression.
Overexpression
CRISPR-mediated overexpression of polyuridylation enzymes or decay factors can enhance pathway activity and reveal rate-limiting steps. Overexpression models are useful for testing whether increased decay accelerates mRNA turnover. They can also be combined with reporter assays to quantify effects on specific transcripts.
How EDITGENE Supports polyuridylation-dependent mRNA catabolic process Research
Researchers studying polyuridylation-dependent mRNA catabolic process-related genes often need to determine whether a candidate gene is causally involved in mRNA stability, whether a specific mutation alters decay activity, or whether overexpression of a decay factor changes transcript half-lives. EDITGENE provides CRISPR-based cell model services that enable these functional studies with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for polyuridylation-dependent mRNA catabolic process research.
Frequently Asked Questions About polyuridylation-dependent mRNA catabolic process
What is polyuridylation-dependent mRNA catabolic process?
It is a biological process in which an mRNA is degraded after a stretch of uridylyl residues is added to its 3' end, as defined by GO:1990074.
What is the GO ID for polyuridylation-dependent mRNA catabolic process?
The GO ID is GO:1990074.
What genes are involved in polyuridylation-dependent mRNA catabolic process?
Genes involved include those encoding polyuridylation enzymes, decay factors, and RNA-binding proteins; specific examples from related literature include BRCA1 and codon optimality-related genes.
How is polyuridylation-dependent mRNA decay regulated?
It is regulated by enzyme availability, target recognition, translation status, and mRNA modifications such as 2'-O-methylation.
Why is polyuridylation-dependent mRNA catabolic process important?
It controls mRNA half-life and gene expression, and its dysregulation is linked to cancer and other diseases.
What methods are used to study polyuridylation-dependent mRNA catabolic process?
Methods include RNA stability assays, poly(U) tail sequencing, ribosome profiling, and fluorescence microscopy.
Is polyuridylation-dependent mRNA catabolic process related to polyadenylation?
Yes, it is conceptually related to polyadenylation-dependent decay in bacteria, archaea, and organelles.
Can CRISPR be used to study polyuridylation-dependent mRNA catabolic process?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are used to dissect gene function in this pathway.
What diseases are associated with defects in mRNA decay?
Cancer and other conditions where mRNA stability is altered; for example, BRCA1 loss stabilizes BRCA1-IRIS mRNA in breast cancer.
How does codon optimality affect polyuridylation-dependent mRNA catabolic process?
Codon optimality influences translation elongation and mRNA stability, which can affect entry into decay pathways.
Conclusion
The polyuridylation-dependent mRNA catabolic process (GO:1990074) is a key mechanism for controlling mRNA stability and gene expression through the addition of a poly(U) tail that triggers transcript degradation. Its integration with translation, codon optimality, and RNA modifications highlights its importance in post-transcriptional regulation. Dysregulation of this pathway has implications for cancer and other diseases, making it a valuable area for further research. Advances in CRISPR-based cell models and RNA sequencing technologies are enabling detailed dissection of the factors and mechanisms involved in polyuridylation-dependent decay. EDITGENE provides comprehensive services to support these studies, from knockout and knock-in models to library screening and bioinformatics analysis.
References
- 1. Li Y et al.. 2024. 2'-O-methylation at internal sites on mRNA promotes mRNA stability.. Mol Cell 84(12):2320-2336.e6 PMID: 38906115
- 2. Sharma S et al.. 2025. Extracellular exosomal RNAs are glyco-modified.. Nat Cell Biol 27(6):983-991 PMID: 40467769
- 3. Hanson G et al.. 2018. Codon optimality, bias and usage in translation and mRNA decay.. Nat Rev Mol Cell Biol 19(1):20-30 PMID: 29018283
- 4. Anderson P et al.. 2006. RNA granules.. J Cell Biol 172(6):803-8 PMID: 16520386
- 5. Shimizu Y et al.. 2012. BRCA1/p220 loss triggers BRCA1-IRIS overexpression via mRNA stabilization in breast cancer cells.. Oncotarget 3(3):299-313 PMID: 22431556
- 6. Mohanty BK et al.. 2011. Bacterial/archaeal/organellar polyadenylation.. Wiley Interdiscip Rev RNA 2(2):256-76 PMID: 21344039
- 7. Griffioen AW et al.. 2019. Cell death rocks.. Apoptosis 24(3-4):205-207 PMID: 30895494
- 8. Holtkamp S et al.. 2006. Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells.. Blood 108(13):4009-17 PMID: 16940422
